Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Research Institute of Geroprotective Technologies is a biotechnology research organization dedicated to the science of longevity and the identification of geroprotective compounds. Based in Moscow, the institute leverages advanced bioinformatics and artificial intelligence to analyze longitudinal health data and biological markers of aging. It is widely recognized for developing the Geroprotectors.org database, which catalogs substances with potential life-extending properties across various species. The institute's work supports the development of therapeutic interventions aimed at slowing the aging process and extending human healthspan. It operates in close synergy with the commercial startup Gero to translate computational findings into drug discovery programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Research Institute of Geroprotective Technologies.